13 Einträge gefunden

1. Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer

   1. Marx, Andreas
   2. Koopmann, Lena
   3. Höflmayer, Doris
   4. Büscheck, Franziska
   5. Hube-Magg, Claudia
   6. Steurer, Stefan
   7. Eichenauer, Till

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer

   1. Höflmayer, Doris
   2. Steinhoff, Amélie
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Simon, Ronald
   6. Burandt, Eike
   7. Tsourlakis, Maria Christina

   2020 - Forschungsinformationssystem des UKE
3. Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers

   1. Minner, Sarah
   2. Lutz, Jannes
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Simon, Ronald
   6. Höflmayer, Doris
   7. Burandt, Eike

   2019 - Forschungsinformationssystem des UKE
4. IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor Features: A tissue microarray study on 8,877 human cancers and normal tissues

   1. Burdelski, Christoph
   2. Jakani-Karimi, Nilofar
   3. Jacobsen, Frank
   4. Möller-Koop, Christina
   5. Minner, Sarah
   6. Simon, Ronald
   7. Sauter, Guido

   2018 - Forschungsinformationssystem des UKE
5. Prevalence of βIII-tubulin (TUBB3) expression in human normal tissues and cancers

   1. Person, Fermín
   2. Wilczak, Waldemar
   3. Hube-Magg, Claudia
   4. Burdelski, Christoph
   5. Möller-Koop, Christina
   6. Simon, Ronald
   7. Noriega, Mercedes

   2017 - Forschungsinformationssystem des UKE - frei zugänglich
6. Diverse expression patterns of the EMT suppressor grainyhead-like 2 (GRHL2) in normal and tumour tissues

   1. Riethdorf, Sabine
   2. Frey, Sabrina
   3. Santjer, Sonja
   4. Stoupiec, Malgorzata
   5. Otto, Benjamin
   6. Riethdorf, Lutz
   7. Koop, Christina

   2015 - Forschungsinformationssystem des UKE
7. Loss of ALCAM expression is linked to adverse phenotype and poor prognosis in breast cancer: a TMA-based immunohistochemical study on 2,197 breast cancer patients

   1. Burandt, Eike
   2. Bari Noubar, Tanaz
   3. Lebeau, Annette
   4. Minner, Sarah
   5. Burdelski, Christoph
   6. Jänicke, Fritz
   7. Müller, Volkmar

   2014 - Forschungsinformationssystem des UKE
8. The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression

   1. Grupp, Katharina
   2. Boumesli, Rebecca
   3. Tsourlakis, Maria Christina
   4. Koop, Christina
   5. Wilczak, Waldemar
   6. Adam, Meike
   7. Sauter, Guido

   2014 - Forschungsinformationssystem des UKE
9. NY-ESO-1 expression is tightly linked to TMPRSS2-ERG fusion in prostate cancer

   1. Grupp, Katharina
   2. Ospina-Klinck, Daniel
   3. Tsourlakis, Maria Christina
   4. Koop, Christina
   5. Wilczak, Waldemar
   6. Adam, Meike
   7. Simon, Ronald

   2014 - Forschungsinformationssystem des UKE
10. High mitochondria content is associated with prostate cancer disease progression

    1. Grupp, Katharina
    2. Jedrzejewska, Karolina
    3. Tsourlakis, Maria Christina
    4. Koop, Christina
    5. Wilczak, Waldemar
    6. Adam, Meike
    7. Quaas, Alexander

    2013 - Forschungsinformationssystem des UKE - frei zugänglich
11. Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.

    1. Burandt, Eike Christian
    2. Jens, G
    3. Holst, Frederik
    4. Jänicke, Fritz
    5. Müller, Volkmar
    6. Quaas, Alexander
    7. Choschzick, Matthias

    2013 - Forschungsinformationssystem des UKE
12. Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma.

    1. Minner, Sarah
    2. Rump, Dorothea
    3. Tennstedt, Pierre
    4. Simon, Ronald
    5. Burandt, Eike Christian
    6. Terracciano, Luigi
    7. Moch, Holger

    2012 - Forschungsinformationssystem des UKE
13. Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer.

    1. El Gammal, Alexander Tarek
    2. Brüchmann, Michael
    3. Zustin, Jozef
    4. Isbarn, Hendrik
    5. Hellwinkel, Olaf
    6. Köllermann, Jens
    7. Sauter, Guido

    2010 - Forschungsinformationssystem des UKE